References
- Addala S, Grines CL, Dixon SR, et al. (2004). Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 93:629–32
- Bardají A, Barrabés JA, Sanchis J, Sanchez PL. (2010). Ischemic heart disease: 2009 update. Rev Esp Cardiol 63:49–60
- Baz JA, Barrabes J, Pinar E, et al. (2009). Técnicas actuales en la angioplastia primaria. Manejo actual del shock cardiogénico. Rev Esp Cardiol 09:17–26
- Cannon CP, Battler A, Brindis RG, et al. (2001). American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 38:2114–30
- Cascón-Pérez JD, Consuegra L, Picó-Aracil F. (2009). Virtual histology of an acute thrombotic occlusive lesion. Rev Esp Cardiol 62:705–6
- Deguchi JO, Aikawa M, Tung CH, et al. (2006). Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 114:55–62
- Ferreira-González I, Permanyer-Miralda G, Marrugat J, et al. (2008). MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado) study. General findings. Rev Esp Cardiol 61:803–16
- Halkin A, Singh M, Nikolsky E, et al. (2005). Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45:1397–405
- Lee CW, Hwang I, Park CS, et al. (2012). Innate immunity markers in culprit plaques of acute myocardial infarction or stable angina. Biomarkers 17:209–15
- Libby P, Simon DI. (2001). Inflammation and thrombosis: the clot thickens. Circulation 103:1718–20
- Libby P, Ridker PM, Hansson GK. (2009). Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54:2129–38
- Kaptoge S, Di Angelantonio E, Lowe G, et al. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:132–40
- Kramer MC, van der Wal AC, Koch KT, et al. (2008). Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation 118:1810–16
- Méndez-Eirín E, Flores-Ríos X, García-López F, et al. (2012). Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI. Rev Esp Cardiol 65:227–33
- Morrow DA, Antman EM, Charlesworth A, et al. (2000). TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031–7
- Park JP, Park MK, Yun JW. (2011). Proteomic biomarkers for diagnosis in acute myocardial infarction. Biomarkers 16:1–11
- Sbarouni E, Georgiadou P, Voudris V. (2011). Gender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures. Biomarkers 16:457–65
- Van de Werf F, Bax J, Betriu A, et al. (2009). Guías de práctica clínica de la Sociedad Europea de Cardiología. Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST. Rev Esp Cardiol 62:e1–e47
- Yunoki K, Naruko T, Sugioka K, et al. (2012). Erythrocyte-rich thrombus aspirated from patients with ST-elevation myocardial infarction: association with oxidative stress and its impact on myocardial reperfusion. Eur Heart J 33:1480–90